PortalPublikationenTopical photodynamic therapy for patients with therapy-resis...

Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

Standard

Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. / Coors, Esther; von den Driesch, Peter.

in: J AM ACAD DERMATOL, Jahrgang 50, Nr. 3, 3, 2004, S. 363-367.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Coors, E & von den Driesch, P 2004, 'Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.', J AM ACAD DERMATOL, Jg. 50, Nr. 3, 3, S. 363-367. <http://www.ncbi.nlm.nih.gov/pubmed/14988676?dopt=Citation>

APA

Coors, E., & von den Driesch, P. (2004). Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J AM ACAD DERMATOL, 50(3), 363-367. [3]. http://www.ncbi.nlm.nih.gov/pubmed/14988676?dopt=Citation

Vancouver

Coors E, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J AM ACAD DERMATOL. 2004;50(3):363-367. 3.

Bibtex

@article{57686486220c4ee2af3aed87dee49e97,
title = "Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.",
abstract = "Photodynamic therapy after topical application of 5-aminolevulinic acid is an effective therapy for nonmelanoma epithelial skin cancers. It has also been used for some cases of cutaneous T-cell lymphoma. We treated 4 patients with different cutaneous T-cell lymphomas with photodynamic therapy. Those patients had previously reached a partial remission with more conventional therapies, but single lesions had remained. In all of these cases a complete remission of these lesions was achieved. We, therefore, suggest that photodynamic therapy can be a useful additional treatment modality for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.",
author = "Esther Coors and {von den Driesch}, Peter",
year = "2004",
language = "Deutsch",
volume = "50",
pages = "363--367",
journal = "J AM ACAD DERMATOL",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

AU - Coors, Esther

AU - von den Driesch, Peter

PY - 2004

Y1 - 2004

N2 - Photodynamic therapy after topical application of 5-aminolevulinic acid is an effective therapy for nonmelanoma epithelial skin cancers. It has also been used for some cases of cutaneous T-cell lymphoma. We treated 4 patients with different cutaneous T-cell lymphomas with photodynamic therapy. Those patients had previously reached a partial remission with more conventional therapies, but single lesions had remained. In all of these cases a complete remission of these lesions was achieved. We, therefore, suggest that photodynamic therapy can be a useful additional treatment modality for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

AB - Photodynamic therapy after topical application of 5-aminolevulinic acid is an effective therapy for nonmelanoma epithelial skin cancers. It has also been used for some cases of cutaneous T-cell lymphoma. We treated 4 patients with different cutaneous T-cell lymphomas with photodynamic therapy. Those patients had previously reached a partial remission with more conventional therapies, but single lesions had remained. In all of these cases a complete remission of these lesions was achieved. We, therefore, suggest that photodynamic therapy can be a useful additional treatment modality for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

M3 - SCORING: Zeitschriftenaufsatz

VL - 50

SP - 363

EP - 367

JO - J AM ACAD DERMATOL

JF - J AM ACAD DERMATOL

SN - 0190-9622

IS - 3

M1 - 3

ER -